BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea
· Delayed Price · Currency is KRW 13,410
-620 (-4.42%)
At close: Mar 9, 2026
BIO-FD&C Revenue
BIO-FD&C had revenue of 5.07B KRW in the quarter ending September 30, 2025, with 40.99% growth. This brings the company's revenue in the last twelve months to 18.82B, up 17.12% year-over-year. In the year 2024, BIO-FD&C had annual revenue of 16.07B with 3.04% growth.
Revenue (ttm)
18.82B
Revenue Growth
+17.12%
P/S Ratio
6.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
116.61B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| IMGT Co.,Ltd. | 102.33M |
| CORESTEMCHEMON | 20.13B |
| NovMetaPharma | 1.30B |
| ViGenCell | 278.95M |
| Progen | 450.00M |
| Quratis | 2.28B |
| Cell Biotech | 50.65B |
| TegoScience | 6.15B |